1.    Introduction

1.1    Scope of the Study

1.2    The Insight Partners Research Report Guidance

1.3    Market Segmentation

1.3.1    North America Neurological Biomarkers Market – By Product

1.3.2    North America Neurological Biomarkers Market – By Application

1.3.3    North America Neurological Biomarkers Market – By End User

1.3.4    North America Neurological Biomarkers Market – By Country

2.    North America Neurological Biomarkers Market – Key Takeaways

3.    Research Methodology

3.1    Coverage

3.2    Secondary Research

3.3    Primary Research

4.     North America Neurological Biomarkers Market – Market Landscape

4.1    Overview

4.2    PEST Analysis

4.2.1    Neurological Biomarkers Market - North America PEST Analysis

4.3    Expert Opinion

5.    North America Neurological Biomarkers Market - Key Market Dynamics

5.1    Key Market Drivers

5.1.1    Growing Prevalence of Neurological Disorders

5.1.2    Increasing Focus Toward Research in Neurological Biomarkers

5.2    Key Market Restraints

5.2.1    Limitations of Neurological Biomarkers

5.3    Market Opportunities

5.3.1    Increasing Awareness Toward Benefits of Early Diagnosis

5.4    Future Trends

5.4.1    Trend Shift Towards Personalized/Precision Medicine

5.5    Impact analysis

6.     Neurological Biomarkers Market – North America Analysis

6.1    North America Neurological Biomarkers Market Revenue Forecasts and Analysis

7.    North America Neurological Biomarkers Market Analysis And Forecasts To 2027 – By Product

7.1    Overview

7.2    North America Neurological Biomarkers market, By Product 2019 & 2027 (%)

7.2.1    North America Neurological Biomarkers Market Revenue and Forecasts to 2027, By Product (US$ Mn)

7.3    Proteomics Biomarker

7.3.1    Overview

7.3.2    North America Proteomics Biomarker Market Revenue and Forecast to 2027 (US$ Mn)

7.4    Genomics Biomarker

7.4.1    Overview

7.4.2    North America Genomics Biomarker Market Revenue and Forecasts to 2027 (US$ Mn)

7.5    Metabolomics Biomarker

7.5.1    Overview

7.5.2    North America Metabolomics Biomarker Market Revenue and Forecasts to 2027 (US$ Mn)

7.6    Imaging Biomarker

7.6.1    Overview

7.6.2    North America Imaging Biomarker Market Revenue and Forecasts to 2027 (US$ Mn)

7.7    Others

7.7.1    Overview

7.7.2    North America Others Market Revenue and Forecasts to 2027 (US$ Mn)

8.     North America Neurological Biomarkers Market Analysis – By Application

8.1    Overview

8.2    North America Neurological Biomarkers Market, By Application 2019-2027 (%)

8.2.1    North America Neurological Biomarkers Market Revenue and Forecasts to 2027, By Application (US$ Mn)

8.3    Alzheimer’s Disease

8.3.1    Overview

8.3.2    North America Alzheimer’s Disease Market Revenue and Forecasts to 2027 (US$ Mn)

8.4    Parkinson’s Disease

8.4.1    Overview

8.4.2    North America Parkinson’s Disease Market Revenue and Forecasts to 2027 (US$ Mn)

8.5    Schizophrenia

8.5.1    Overview

8.5.2    North America Schizophrenia Market Revenue and Forecasts to 2027 (US$ Mn)

8.6    Huntington's Disease

8.6.1    Overview

8.6.2    North America Huntington's Disease Market Revenue and Forecasts to 2027 (US$ Mn)

8.7    Spinal Muscular Atrophy

8.7.1    Overview

8.7.2    North America Spinal Muscular Atrophy Market Revenue and Forecasts to 2027 (US$ Mn)

8.8    Others

8.8.1    Overview

8.8.2    North America Others Market Revenue and Forecasts to 2027 (US$ Mn)

9.     North America Neurological Biomarkers Market Analysis – By End User

9.1    Overview

9.2    North America Neurological Biomarkers Market, By End User 2019-2027 (%)

9.2.1    North America Neurological Biomarkers Market Revenue and Forecasts to 2027, By End User (US$ Mn)

9.3    Pharmaceutical and Biotechnology Companies

9.3.1    Overview

9.3.2    North America Pharmaceutical and Biotechnology Companies Market Revenue and Forecasts to 2027 (US$ Mn)

9.4    Clinical Diagnostics

9.4.1    Overview

9.4.2    North America Clinical Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)

9.5    Research Organizations

9.5.1    Overview

9.5.2    North America Research Organizations Market Revenue and Forecasts to 2027 (US$ Mn)

10.    Neurological Biomarkers Market Revenue and Forecasts To 2027 – Geographical Analysis

10.1    North America: Neurological Biomarker Market

10.1.1    Overview

10.1.2    North America: Neurological Biomarker Market – Revenue and Forecast to 2027 (USD Million)

10.1.3    North America: Neurological Biomarker Market, by Product, 2018–2027 (USD Million)

10.1.4    North America: Neurological Biomarker Market, by Application, 2018–2027 (USD Million)

10.1.5    North America: Neurological Biomarker Market, by End-User, 2018–2027 (USD Million)

10.1.6    North America: Neurological Biomarker Market, by Country, 2019& 2027 (%)

10.1.7    US: Neurological Biomarker Market – Revenue and Forecast to 2027 (USD Million)

10.1.7.1   US: Neurological Biomarker Market – Revenue and Forecast to 2027 (USD Million)

10.1.7.2   US: Neurological Biomarker Market, by Product, 2018–2027 (USD Million)

10.1.7.3   US: Neurological Biomarker Market, by Application, 2018–2027 (USD Million)

10.1.7.4   US: Neurological Biomarker Market, by End-User, 2018–2027 (USD Million)

10.1.8    Canada: Neurological Biomarker Market – Revenue and Forecast to 2027 (USD Million)

10.1.8.1   Canada: Neurological Biomarker Market – Revenue and Forecast to 2027 (USD Million)

10.1.8.2   Canada: Neurological Biomarker Market, by Product, 2018–2027 (USD Million)

10.1.8.3   Canada: Neurological Biomarker Market, by Application, 2018–2027 (USD Million)

10.1.8.4   Canada: Neurological Biomarker Market, by End-User, 2018–2027 (USD Million)

10.1.9    Mexico: Neurological Biomarker Market – Revenue and Forecast to 2027 (USD Million)

10.1.9.1   Mexico: Neurological Biomarker Market – Revenue and Forecast to 2027 (USD Million)

10.1.9.2   Mexico: Neurological Biomarker Market, by Product, 2018–2027 (USD Million)

10.1.9.3   Mexico: Neurological Biomarker Market, by Application, 2018–2027 (USD Million)

10.1.9.4   Mexico: Neurological Biomarker Market, by End-User, 2018–2027 (USD Million)

11.   Impact of COVID-19 Pandemic on North America Neurological Biomarkers Market

11.1    North America: Impact Assessment of COVID-19 Pandemic

12.    Company Profiles

12.1    Thermo Fisher Scientific Inc.

12.1.1    Key Facts

12.1.2    Business Description

12.1.3    Products and Services

12.1.4    Financial Overview

12.1.5    SWOT Analysis

12.1.6    Key Developments

12.2    Abbott

12.2.1    Key Facts

12.2.2    Business Description

12.2.3    Products and Services

12.2.4    Financial Overview

12.2.5    SWOT Analysis

12.2.6    Key Developments

12.3    Bio-Rad Laboratories Inc.

12.3.1    Key Facts

12.3.2    Business Description

12.3.3    Products and Services

12.3.4    Financial Overview

12.3.5    SWOT Analysis

12.3.6    Key Developments

12.4    Banyan Biomarkers, Inc

12.4.1    Key Facts

12.4.2    Business Description

12.4.3    Products and Services

12.4.4    Financial Overview

12.4.5    SWOT Analysis

12.4.6    Key Developments

12.5    Quest Diagnostics Incorporated

12.5.1    Key Facts

12.5.2    Business Description

12.5.3    Products and Services

12.5.4    Financial Overview

12.5.5    SWOT Analysis

12.5.6    Key Developments

12.6    Perkin Elmer, Inc.

12.6.1    Key Facts

12.6.2    Business Description

12.6.3    Products and Services

12.6.4    Financial Overview

12.6.5    SWOT Analysis

12.6.6    Key Developments

13.    Appendix

13.1    About the Insight Partners

13.2    Word Index

LIST OF TABLES

Table 1.    North America Neurological Biomarkers Market Revenue and Forecasts To 2027, By Product (US$ Mn)

Table 2.    North America Neurological Biomarkers Market Revenue and Forecasts To 2027, By Application (US$ Mn)

Table 3.    North America Neurological Biomarkers Market Revenue and Forecasts To 2027, By End User (US$ Mn)

Table 4.    North America Neurological Biomarker Market, by Product – Revenue and Forecast to 2027 (USD Million)

Table 5.    North America Neurological Biomarker Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 6.    North America Neurological Biomarker Market, by End-User– Revenue and Forecast to 2027 (USD Million)

Table 7.    US Neurological Biomarker Market, by Product – Revenue and Forecast to 2027 (USD Million)

Table 8.    US Neurological Biomarker Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 9.    US Neurological Biomarker Market, by End-User– Revenue and Forecast to 2027 (USD Million)

Table 10.    Canada Neurological Biomarker Market, by Product – Revenue and Forecast to 2027 (USD Million)

Table 11.    Canada Neurological Biomarker Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 12.    Canada Neurological Biomarker Market, by End-User– Revenue and Forecast to 2027 (USD Million)

Table 13.    Mexico Neurological Biomarker Market, by Product – Revenue and Forecast to 2027 (USD Million)

Table 14.    Mexico Neurological Biomarker Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 15.    Mexico Neurological Biomarker Market, by End-User– Revenue and Forecast to 2027 (USD Million)

Table 16.    List of Abbreviation

LIST OF FIGURES

Figure 1.    Neurological Biomarkers Market Segmentation

Figure 2.    North America Neurological Biomarkers Market Overview

Figure 3.    Genomic Biomarkers Segment Held Largest Share of Neurological Biomarker Market

Figure 4.    US is Expected to Show Remarkable Growth During the Forecast Period

Figure 5.    North America Neurological Biomarkers Market - Leading Country Markets (US$ Mn)

Figure 6.    Neurological Biomarkers Market - North America PEST Analysis

Figure 7.    Neurological Biomarkers Market Impact Analysis Of Driver And Restraints

Figure 8.    North America Neurological Biomarkers market – Revenue Forecasts and Analysis – 2019- 2027

Figure 9.    North America Neurological Biomarkers market, By Product 2019 & 2027 (%)

Figure 10.    North America Proteomics Biomarker Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 11.    North America Genomics Biomarker Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 12.    North America Metabolomics Biomarker Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 13.    North America Imaging Biomarker Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 14.    North America Others Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 15.    North America Neurological Biomarkers Market, by Application 2019 & 2027 (%)

Figure 16.    North America Alzheimer’s Disease Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 17.    North America Parkinson’s Disease Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 18.    North America Schizophrenia Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 19.    North America Huntington's Disease Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 20.    North America Spinal Muscular Atrophy Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 21.    North America Others Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 22.    North America Neurological Biomarkers Market, by End User 2019 & 2027 (%)

Figure 23.    North America Pharmaceutical and Biotechnology Companies Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 24.    North America Clinical Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 25.    North America Research Organizations Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 26.    North America: Neurological Biomarker Market, by Key Country – Revenue (2019) (USD Million)

Figure 27.    North America Neurological Biomarker Market Revenue and Forecast to 2027 (USD Million)

Figure 28.    North America: Neurological Biomarker Market, by Country, 2019 & 2027 (%)

Figure 29.    US: Neurological Biomarker Market – Revenue and Forecast to 2027 (USD Million)

Figure 30.    Canada: Neurological Biomarker Market – Revenue and Forecast to 2027 (USD Million)

Figure 31.    Mexico: Neurological Biomarker Market – Revenue and Forecast to 2027 (USD Million)

Figure 32.    Impact of COVID-19 Pandemic in North American Country Markets